Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

16. August 2021 16:01 ET | Quelle: Vyant Bio, Inc.

Vyant Bio Reports Second Quarter 2021 Results and Provides Strategic Business Updates

Strategic Highlights Received an issued US Patent titled “High Throughput Optical Assay of Human Mixed Cell Population Spheroids” by the United States...
22. April 2021 08:00 ET | Quelle: Vyant Bio, Inc.

Vyant Bio, Inc., Ordaōs Bio, and Cellaria, Inc. Announce Collaboration to Design and Qualify Biomarker-Specific Small Protein Therapeutics

New collaboration mitigates risk in drug discovery process with artificial intelligence and in vitro “avatar” clinical trials CHERRY HILL, N.J., April 22, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc....
20. März 2017 08:43 ET | Quelle: Cellaria Bio

Cellaria Adds Next-Generation RNA Reprogramming and Stem Cell Services

CAMBRIDGE, Mass., March 20, 2017 (GLOBE NEWSWIRE) -- Cellaria, LLC, a scientific innovator that develops revolutionary new cancer models for challenging tumors, today announced the expansion of its...
09. Februar 2017 12:11 ET | Quelle: Cellaria Bio

Cellaria Forms Strategic Partnership with AMS Biotechnology

CAMBRIDGE, Mass., Feb. 09, 2017 (GLOBE NEWSWIRE) -- Cellaria, LLC, a scientific innovator that develops revolutionary new patient-specific cancer models for challenging tumors, today announced the...
15. November 2016 12:33 ET | Quelle: Cellaria Bio

Cellaria to Release Novel Ovarian and Breast Cancer Cell Models

CAMBRIDGE, Mass., Nov. 15, 2016 (GLOBE NEWSWIRE) -- Cellaria, LLC, a scientific innovator that develops revolutionary new cancer models for challenging tumors, today announced the release of two new...